Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 18, 2021
Monitoring of Donor-Derived Cell-Free DNA by Short Tandem Repeats: Concentration of Total Cell-Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver TransplantationEsther Fernández-Galán, Celia Badenas, Constantino Fondevila, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 22, 2024
Calculation of reference intervals for the concentrations of α-tocopherol and retinol in serum using indirect data-mining proceduresRaúl Rigo-Bonnin, Irene Aliart-Fernández, Anna Escalante-Vilanova, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 3, 2020
MicroRNAs 155-5p, 122-5p, and 181a-5p Identify Patients With Graft Dysfunction Due to T Cell-Mediated Rejection After Liver TransplantationPablo Ruiz, Olga Millán, Jose Ríos, et al.
Frontiers in Immunology|June 16, 2023
A plasmatic score using a miRNA signature and CXCL-10 for accurate prediction and diagnosis of liver allograft rejectionOlga Millán, Pablo Ruiz, Judit Julian, et al.
The Journal of Antimicrobial Chemotherapy|February 18, 2022
Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infectionsCarla Bastida, María Hernández-Tejero, Marcial Cariqueo, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2020
Meropenem population pharmacokinetics in patients with decompensated cirrhosis and severe infectionsCarla Bastida, María Hernández-Tejero, Fátima Aziz, et al.
British Journal of Clinical Pharmacology|February 23, 2021
Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN studyClaudia Sommerer, Mercè Brunet, Klemens Budde, et al.
Clinical Immunology (Orlando, Fla.)|July 4, 2021
Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantationOlga Millán, Jordi Rovira, Lluis Guirado, et al.
Pharmaceutics|March 27, 2025
Pharmacogenetic Influences on Individual Responses to Ocular Hypotensive Agents in Glaucoma PatientsSara Labay-Tejado, Virginia Fortuna, Néstor Ventura-Abreu, et al.
Frontiers in Immunology|May 10, 2019
Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in de novo Adult Liver Transplant RecipientsOlga Millán, Pablo Ruiz, Lara Orts, et al.
Pageof 8